Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionLogin 
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 348 Print this page  Email this page Small font size Default font size Increase font size
INTERESTING IMAGE
Year : 2022  |  Volume : 37  |  Issue : 3  |  Page : 277-278

F-18 PSMA uptake in male breast cancer during restaging evaluation of carcinoma prostate


1 Department of Nuclear Medicine, Apollo Hospitals, Sector 23, CBD Belapur, Navi Mumbai, India
2 Department of Oncosurgery, Apollo Hospitals, Sector 23, CBD Belapur, Navi Mumbai, India
3 Department of Pathology, Apollo Hospitals, Sector 23, CBD Belapur, Navi Mumbai, India

Correspondence Address:
Dr. Anand Zade
Department of Nuclear Medicine, Apollo Hospitals, Sector 23, CBD Belapur, Navi Mumbai - 400 614, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijnm.ijnm_127_21

Rights and Permissions

Fluorine-18 prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography scan is widely used for restaging of prostate cancer. We present a case where false-positive PSMA uptake was seen in metachronous carcinoma breast during restaging workup of carcinoma prostate.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed126    
    Printed6    
    Emailed0    
    PDF Downloaded22    
    Comments [Add]    

Recommend this journal